Circulating obestatin levels in normal and Type 2 diabetic subjects

Journal of Endocrinological Investigation

Volumn 33, Issue 4, 2010, Pages 211-214

  St Pierre, D H ^a   Settanni, F ^a   Olivetti, I ^a   Gramaglia, E ^a   Tomelini, M ^a   Granata, R ^a   Prodam, F ^a   Benso, A ^a   Ghigo, E ^a   Broglio, F ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Diabetes; Glucose; Insulin; Obestatin

Indexed keywords

GLUCOSE; INSULIN; OBESTATIN; SODIUM CHLORIDE; GHRELIN; GLUCOSE BLOOD LEVEL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLYCEMIC INDEX; HUMAN; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN SECRETION; AGED; BLOOD; DIET RESTRICTION; EATING; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EATING; FASTING; GHRELIN; HUMANS; INSULIN; MALE; MIDDLE AGED;

EID: 77953597024     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03345780     Document Type: Article

References (28)

1. Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310: 996-9.
2. Lagaud GJ, Young A, Acena A, Morton MF, Barrett TD, Shankley NP. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun 2007, 357: 264-9.
3. Bresciani E, Rapetti D, Dona F, et al. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J Endocrinol Invest 2006, 29: RC16-8.
4. Gourcerol G, Coskun T, Craft LS, et al. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity (Silver Spring) 2007, 15: 2643-52.
5. Gourcerol G, Million M, Adelson DW, et al. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents. Peptides 2006, 27: 2811-9.
6. Bassil AK, Haglund Y, Brown J, et al. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol 2007, 150: 58-64. (Pubitemid 46094669)
7. De Smet B, Thijs T, Peeters TL, Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil 2007, 19: 211-7.
8. Depoortere I, Thijs T, Moechars D, De Smet B, Ver Donck L, Peeters TL. Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice. Br J Pharmacol 2008, 153: 1550-7.
9. Kobelt P, Wisser AS, Stengel A, et al. Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents. Peptides 2008, 29: 1018-27.
10. Nogueiras R, Pfluger P, Tovar S, et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007, 148: 21-6.
11. Granata R, Settanni F, Gallo D, et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 2008, 57: 967-79.
12. Ren AJ, Guo ZF, Wang YK, et al. Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun 2008, 369: 969-72.
13. Gao XY, Kuang HY, Liu XM, et al. Decreased obestatin in plasma in metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract 2008, 79: e5-6.
14. Guo ZF, Zheng X, Qin YW, Hu JQ, Chen SP, Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab 2007, 92: 1875-80.
15. Haider DG, Schindler K, Prager G, et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007, 92: 1168-71.
16. Harada T, Nakahara T, Yasuhara D, et al. Obestatin, acyl ghrelin, and des-acyl ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biol Psychiatry 2008, 15: 245-7.
17. Huda MS, Durham BH, Wong SP, et al. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obes (Lond) 2008, 32: 129-35.
18. Nakahara T, Harada T, Yasuhara D, et al. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 2008, 64: 252-5.
19. Qi X, Li L, Yang G, et al. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus. Clin Endocrinol (Oxf) 2007, 66: 593-7.
20. Reinehr T, de Sousa G, Roth CL. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin Endocrinol (Oxf) 2008, 68: 304-10.
21. Anderwald-Stadler M, Krebs M, Promintzer M,et al. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab 2007, 293: E1393-8.
22. Fontenot E, DeVente JE, Seidel ER. Obestatin and ghrelin in obese and in pregnant women. Peptides 2007, 28: 1937-44.
23. Beasley JM, Ange BA, Anderson CA, et al. Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin). Obesity (Silver Spring) 2009, 17: 349-54.
24. Lippl F, Erdmann J, Lichter N, et al. Relation of plasma obestatin levels to bmi, gender, age and insulin. Horm Metab Res 2008, 40: 806-12.
25. Zamrazilova H, Hainer V, Sedlackova D, et al. Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res 2008, 57 (Suppl 1): S49-55.
26. Lauwers E, Landuyt B, Arckenś L, Schoofs L, Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 2006, 351: 21-5.
27. Holst B, Egerod KL, Schild E, et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 2007, 148: 13-20. (Pubitemid 46021433)
28. Sun Y, Asnicar M, Smith RG. Central and peripheral roles of ghrelin on glucose homeostasis. Neuroendocrinology 2007, 86: 215-28.